AN41--dPCR Assay Design Services

The Veterans Health Administration (VHA), Office of Research and Development (R&D), Regional Procurement Office (RPO) East in Pittsburgh, PA intends to negotiate on a sole source basis with Qiagen, LLC. The requirement is for the procurement of dPCR Assay Design Services, synthesis, and wet lab validation of primer sets for short copy number variants (CNV) analysis. This procurement is being conducted IAW FAR 6.302-1, Only one responsible source and no other supplies will satisfy agency requirements; and VHAPM Part 806.3, Other Than Full and Open Competition less than SAT for Open Market Items. This is because the Government asserts that Qiagen, LLC is the only contractor that can provide the large-scale testing required by the Government. The Government requires dPCR assay design services at a scale that can only be accomplished by Qiagen, LLC. Alternate forms of testing, such as microarray testing, are not capable of meeting the Governments budgetary and project size requirements. This notice of intent is not a request for competitive proposals. However, any responsible source who believes it is capable of meeting the requirement may submit a capability statement and supporting documentation to the Contract Specialist no later than Thursday, March 17th, 2022, (2:00 PM, EST). Interest/capability statements may be sent by email to Anthony LeAnder at [email protected]. No telephone responses will be accepted. A determination not to compete the proposed requirement based upon the responses to this notice is solely within the discretion of the Government.